11.08.2020 • Webinar

Platformizaton of Molecular Design

The majority of the ten most valuable companies on the planet are digital platform companies. All of those platforms are ecosystems where value-generating interactions between groups of people take place based on real-time analysis of data streams.   How far away from that new reality, which emerged over the past decade, are research organizations in the field of Molecular Design?   The Schrödinger Molecular Design Platform integrates physics-based predictive modeling, machine / deep learning and enterprise informatics; case studies will illustrate its utilization.

Who Should Attend the Webinar?

  • chemists, especially in research and development
  • chemistry managers
  • data scientists in chemistry

  Key Learning Objectives

  • current status of simulations in chemical and pharmaceutical research
  • capabilities of data-based models and scientific computations
  • computer generated and experimental data democratization
  • enabling innovation via an augmented molecular design platform

Company

Logo:

Schrödinger GmbH

Thierschstraße 27
80538 München
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read